ATP5E_HUMAN - dbPTM
ATP5E_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID ATP5E_HUMAN
UniProt AC P56381
Protein Name ATP synthase subunit epsilon, mitochondrial {ECO:0000305}
Gene Name ATP5F1E {ECO:0000312|HGNC:HGNC:838}
Organism Homo sapiens (Human).
Sequence Length 51
Subcellular Localization Mitochondrion. Mitochondrion inner membrane.
Protein Description Mitochondrial membrane ATP synthase (F(1)F(0) ATP synthase or Complex V) produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain. F-type ATPases consist of two structural domains, F(1) - containing the extramembraneous catalytic core, and F(0) - containing the membrane proton channel, linked together by a central stalk and a peripheral stalk. During catalysis, ATP synthesis in the catalytic domain of F(1) is coupled via a rotary mechanism of the central stalk subunits to proton translocation. Part of the complex F(1) domain and of the central stalk which is part of the complex rotary element. Rotation of the central stalk against the surrounding alpha(3)beta(3) subunits leads to hydrolysis of ATP in three separate catalytic sites on the beta subunits (By similarity)..
Protein Sequence MVAYWRQAGLSYIRYSQICAKAVRDALKTEFKANAEKTSGSNVKIVKVKKE
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
11PhosphorylationYWRQAGLSYIRYSQI
HHHHCCCCHHHHHHH
20.0028152594
12PhosphorylationWRQAGLSYIRYSQIC
HHHCCCCHHHHHHHH
8.4128152594
15PhosphorylationAGLSYIRYSQICAKA
CCCCHHHHHHHHHHH
8.7228152594
16PhosphorylationGLSYIRYSQICAKAV
CCCHHHHHHHHHHHH
11.8328152594
21SuccinylationRYSQICAKAVRDALK
HHHHHHHHHHHHHHH
42.90-
21SuccinylationRYSQICAKAVRDALK
HHHHHHHHHHHHHHH
42.90-
21MalonylationRYSQICAKAVRDALK
HHHHHHHHHHHHHHH
42.9026320211
21UbiquitinationRYSQICAKAVRDALK
HHHHHHHHHHHHHHH
42.9022817900
21AcetylationRYSQICAKAVRDALK
HHHHHHHHHHHHHHH
42.9019608861
28UbiquitinationKAVRDALKTEFKANA
HHHHHHHHHHHHHHH
47.9629967540
28AcetylationKAVRDALKTEFKANA
HHHHHHHHHHHHHHH
47.9625953088
28SuccinylationKAVRDALKTEFKANA
HHHHHHHHHHHHHHH
47.9623954790
29PhosphorylationAVRDALKTEFKANAE
HHHHHHHHHHHHHHH
47.7220833797
32SuccinylationDALKTEFKANAEKTS
HHHHHHHHHHHHCCC
34.20-
32AcetylationDALKTEFKANAEKTS
HHHHHHHHHHHHCCC
34.2025953088
32SuccinylationDALKTEFKANAEKTS
HHHHHHHHHHHHCCC
34.2027452117
37SuccinylationEFKANAEKTSGSNVK
HHHHHHHCCCCCCCE
45.65-
37AcetylationEFKANAEKTSGSNVK
HHHHHHHCCCCCCCE
45.6525953088
37SuccinylationEFKANAEKTSGSNVK
HHHHHHHCCCCCCCE
45.65-
44AcetylationKTSGSNVKIVKVKKE
CCCCCCCEEEEEECC
46.1323749302
44UbiquitinationKTSGSNVKIVKVKKE
CCCCCCCEEEEEECC
46.1329967540
44SuccinylationKTSGSNVKIVKVKKE
CCCCCCCEEEEEECC
46.1323954790

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of ATP5E_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of ATP5E_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of ATP5E_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CP17A_HUMANCYP17A1physical
21988832
ATPD_HUMANATP5Dphysical
26344197
ATP5I_HUMANATP5Iphysical
26344197
ATP5J_HUMANATP5Jphysical
26344197

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
614053Mitochondrial complex V deficiency, nuclear 3 (MC5DN3)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of ATP5E_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-21, AND MASS SPECTROMETRY.

TOP